Beijing Tongren Hospital
Beijing, Beijing Municipality, 100730, China
NCT Number: NCT03940144
The investigators conduct this randomized assessor-blinded controlled trial to evaluate the effect of SVV-guided fluid therapy on postoperative morbidity and mortality in comparison with conventional fluid therapy after major abdominal surgery. Half of participants will receive GDFT perioperatively, and the others will receive conventional fluid therapy
Looking for future studies?
Notify Me16 year and older
All sexes
Interventional
Not applicable
Beijing, Beijing Municipality, 100730, China
Perioperative fluid management has been recognized as an important factor with an impact on postoperative recovery following major abdominal surgery. However, the optimal fluid management is difficult to achieve using standard parameters (e.g., heart rate [HR], blood pressure [BP], central venous pressure[CVP], or urine output) that poorly estimate preload and preload responsiveness. Goal-directed fluid therapy (GDFT) was proposed by introducing different hemodynamic variables into a dynamic perspective of individual fluid loading with or without vasoactive substances to reach predefined goal of optimal preload and/or oxygen delivery.There have been increasing numbers of studies evaluating the effect of perioperative GDFT on postoperative recovery following major abdominal surgery. However, the evidence for the beneficial effect of GDFT on postoperative recovery remains inconsistent.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Stroke volume variation (SVV)-guided fluid therapy
Time frame: from the end of surgery to discharge from hospital up to 30 days after surgery
from the end of surgery to discharge from hospital
Time frame: from the end of surgery to 30 days after surgery
number of participants with I-FEED score >6
Time frame: from the end of surgery to 1 year after surgery
death after surgery
Time frame: 1 day, 3 days and 5 days after surgery
VAS for pain :0 no pain and 10 for worst pain
Time frame: 1 day, 3 days and 5 days after surgery
QoR-15 :quality of recovery score : 0 worst recovery quality and 150 for best recovery
Time frame: from end of surgery to 30 days after surgery
number of any complications after surgery
Beijing Tongren Hospital
Other
Department of Anesthesiology, Beijing Tong Ren Hospital Capital Medical University
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06810648
Colorectal Surgery, Conventional Fluid Therapy
Athens, Attica, Greece
View Trial DetailsNCT03237351
Acute Lung Injury, Goal-directed Fluid Therapy
Shenzhen, Guangdong, China
View Trial DetailsNCT03128190
Goal-directed Fluid Therapy, Hemodynamics Instability
View Trial DetailsNCT06459141
Acute Normovolemic Hemodilution, Bone Diseases
Hangzhou, Zhejiang, China
View Trial Details